Please Wait
Applying Filters...
menu
    • menu
    Alchem offers Phytochemical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Boehringer Ingelheim GmbH

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    micAlchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    With increasing flavour bans in key markets, vaping brands are facing significant challenges in providing satisfying alternatives to vapers and smokers looking to transition. Recognising this need, Alchem NicSelect™ is making a bold move by offering its key customers royalty-free and unrestricted geographical access to its revolutionary T-MAX™ technology.“At Alchem NicSelect™, we understand the urgency for vaping brands to adapt to new regulations without compromising on satisfaction. By offering royalty-free access to T-MAX™ technology, we empower our customers to provide the closest cigarette-like experience possible, even in markets with strict flavour restrictions,” said Riccardo Santambrogio, Europe Sales Manager.HIGHLIGHTS// offering royalty-free access to T-MAX™ technology/ unrestricted geographical access/ closest cigarette-like experience Addressing the biggest barrier: Nicotine satisfactionOne of the primary reasons many vapers are dissatisfied and smokers struggle to switch to vaping is that traditional nicotine solutions fail to replicate the rapid satisfaction provided by cigarettes. Nicotine replacement therapies (NRTs) and even conventional vaping products often lack the immediate nicotine hit, throat feel, and overall experience that smokers are accustomed to. T-MAX™ solves this problem by engineering a nicotine experience that closely mimics cigarette consumption without relying on flavours.T-MAX™ provides a unique 3-in-1 approach:1. The Speed of a Cigarette – Rapid nicotine delivery and rush within seconds for immediate satisfaction.2. The Power of Nicotine Salts – A stronger perceived nicotine effect without exceeding legal limits (20 mg/ml nicotine limit under the European Tobacco Products Directive). With T-MAX™, 8 mg/ml feels like 20 mg/ml, and 14 mg/ml feels like 40 mg/ml.3. The Throat Hit of Freebase Nicotine – Especially in a flavour-free formulation, the combined ingredients in T-MAX™ deliver an even more satisfying throat feel than expected from nicotine base, much closer to and more familiar with a cigarette throat feel that habitual smokers recognise.HIGHLIGHTS// unique 3-in-1 approach/ rush within seconds/ stronger perceived nicotine effect without exceeding legal limits/ more satisfying throat feel that habitual smokers recogniseNo flavour, but not less satisfyingWhile flavours have traditionally played a role in vaping adoption, market realities are shifting. With flavour bans spreading across regions, brands need solutions that deliver satisfaction without relying on taste. Consumer research has shown that T-MAX™ performs exceptionally well even without added flavours. Since most cigarette smokers do not smoke for the tobacco flavour but rather for the nicotine hit and habitual experience, T-MAX™ provides a viable alternative that aligns with new regulatory landscapes.HIGHLIGHTS// flavour bans spreading across regions/ T-MAX™ performs exceptionally well even without added flavoursEmpowering vape brands with free access to T-MAX™By granting customers royalty-free access to the T-MAX™ technology, Alchem NicSelect™ is removing barriers for vaping brands and original equipment manufacturers (OEMs) looking to adapt to regulatory changes. This open-access approach ensures that manufacturers can integrate T-MAX™ into their product lines without additional costs, allowing them to offer superior nicotine satisfaction in markets where flavours are no longer an option.HIGHLIGHTS// removing barriers for vaping brands and OEMs looking to adapt/ manufacturers can integrate T-MAX™ into product lines without additional costsThe future of vaping in restricted marketsWith T-MAX™, the vaping industry has a powerful tool to retain customers and convert smokers who have struggled with traditional vaping products. By delivering the key elements of cigarette satisfaction — without combustion or flavours — T-MAX™ is set to redefine what a satisfying vape experience means in a post-flavour-ban world.“Our commitment to innovation and accessibility means we are providing our customers with the solutions they need to navigate an evolving regulatory landscape. T-MAX™ allows brands to offer a highly satisfying experience that mimics smoking without relying on flavours. The message is clear: no flavour, but not less satisfying”, added Santambrogio.HIGHLIGHTS// powerful tool to retain customers and convert smokers/ delivering the key elements of cigarette satisfaction without combustion or flavours/ no flavour, but not less satisfying

    Impressions: 1328

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets

    Radio Compass
    06 May 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaYour Global Ally in the Pharmaceutical IndustryYour Global Ally in the Pharmaceutical Industry

    Your Global Ally in the Pharmaceutical Industry
    Your Global Ally in the Pharmaceutical Industry

    reelYour Global Ally in the Pharmaceutical Industry

    This PharmaReel highlights Gentec Pharmaceutical's expertise in generic APIs, HPAPIs, and prostaglandins with more than 30 years of experience. Operating from EU-GMP-certified facilities, the company exports to over 70 countries worldwide.

    Impressions: 401

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    CDMO Activity Tracker: Veranova, Carbogen lead ADC investments; Axplora, Polfa Tarchomin, Famar expand European footprint

    CDMO Activity Tracker: Veranova, Carbogen lead ADC investments; Axplora, Polfa Tarchomin, Famar expand European footprint

    During the second quarter (Q2) of 2025, contract development and manufacturing organizations (CDMOs) made substantial investments in specialized therapeutic manufacturing. The quarter also saw CDMOs pursue high-value, complex manufacturing niches, particularly in antibody-drug conjugates (ADCs), cell and gene therapies (CGTs) and oligonucleotides.Alongside these trends, Q2 also saw CDMOs strengthen their footprint in the United States amid concerns over rising tariffs and unpredictable trade policies being enforced by the Trump administration.Regeneron Pharmaceuticals committed over US$ 3 billion through a 10-year agreement with Fujifilm Diosynth Biotechnologies to nearly double its US manufacturing capacity for biologics. Under this agreement, Fujifilm will manufacture and supply drug products for Regeneron at its large-scale facility in Holly Springs, North Carolina.Thermo Fisher Scientific announced plans to invest an additional US$ 2 billion in the US over four years, reinforcing its manufacturing and R&D capabilities. With 64 facilities spread across 37 states, Thermo Fisher aims to bolster American innovation and competitiveness. Similarly, Piramal Pharma announced a US$ 90 million investment plan for expanding two facilities in the US, thereby bringing its total investment in the country to US$ 570 million. View CDMO Activity Tracker for Q2 2025 (Free Excel Available)Veranova, Carbogen lead ADC wave; Axplora doubles down on HPAPI production in ItalyThe quarter saw substantial investments in ADC manufacturing. Veranova announced a US$ 20 million investment in bioconjugation development and cGMP manufacturing capacity at its Devens, Massachusetts campus. With this investment, Veranova will be able to provide a more comprehensive suite of services to its partners developing ADCs and other bioconjugates. Veranova’s total investment in the Devens facility now stands at over US$ 50 million. Swiss CDMO Carbogen announced a US$ 31 million co-investment with an unnamed Japanese investor to expand its capabilities across its Aarau and Neuland (Switzerland) facilities. The facility will address increasing demand for complex and high-value compounds such as ADC drug linkers.Axplora announced a further €35 million (US$ 41 million) expansion of its Farmabios site in Italy, doubling the facility to approximately 108,000 square meters by mid-2026. This investment raises its total spend on the site to over €80 million (US$ 94.05 million) since 2019, supporting the production of highly potent active pharmaceutical ingredients (HPAPIs). Farmabios now stands as a key hub in Axplora’s global CDMO network.Polish pharmaceutical manufacturer Polfa Tarchomin is positioning itself as a significant player in the European CDMO market through its investment in the Center for Development and Production of Highly Potent Drugs. This 12,000 square meter facility has two state-of-the-art production lines designed for filling vials and pre-filled syringes with an annual capacity of 26 million product units.Skyepharma’s projected annual revenues from oncology-linked activities touched €10 million (US$ 11.2 million). The CDMO’s facility in Saint-Quentin-Fallavier is equipped to handle cytotoxic and cytostatic compounds, and is one of the few facilities in France capable of managing HPAPIs for oral anticancer treatments. View CDMO Activity Tracker for Q2 2025 (Free Excel Available) Athena acquires Medipha Santé, Famar buys MiP Pharma’s German site to strengthen European footprintDuring the quarter, several CDMOs enhanced their strategic capabilities through M&As. Athena Pharmaceutiques acquired  Medipha Santé to build a fully integrated pharmaceutical services platform in Europe. Based in Paris, Athena has strengthened its commercial and regulatory toolbox by bringing aboard Medipha Santé’s 35-strong team, which supports over 100 partner organizations and files approximately 350 dossiers annually with ANSM and other European agencies. With this integration, Athena positions itself as a one-stop CDMO partner.With the acquisition of MiP Pharma’s sterile manufacturing site in Homburg, Germany, the Famar Group has expanded its capabilities in aseptic and lyophilized fill-and-finish operations. The acquisition has strengthened Famar’s position in sterile drug manufacturing. The CDMO now has seven manufacturing facilities in Europe.PCI Pharma Services’ acquisition of Ajinomoto Althea has established a world-class, large-scale manufacturing hub in the San Diego region with state-of-the-art aseptic facilities for prefilled syringes, cartridges and high-potent formulations such as ADCs. PCI Pharma is now amongst the few US-based CDMOs capable of comprehensive ADC manufacturing.Samsung Biologics’ strategic spinoff of its biosimilar business stood out as a significant corporate restructuring exercise during the quarter. The separation of Samsung Bioepis, tentatively renamed Samsung Epis Holdings, aims to enhance Samsung Biologics’ strategic focus and build client trust, as it eliminates potential conflicts between CDMO services and proprietary drug development. The move came after Samsung Biologics inked a contract worth 737.3 billion Korean won (US$ 518 million) with an undisclosed US pharmaceutical company.WuXi Biologics announced a US$ 167 million divestment of its German facility to Terumo and broke ground on a microbial production plant in China. National Resilience, which was launched five years ago as the US drug manufacturer dedicated to broadening access to medicines and protecting biopharma supply chains, said it is shuttering six of its 10 facilities. The company said the sites were “not being fully utilized.” View CDMO Activity Tracker for Q2 2025 (Free Excel Available) MilliporeSigma, Simtra form 5-year ADC alliance; Silexion partners Catalent for siRNA developmentMerck KGaA’s MilliporeSigma and Simtra struck a five-year strategic alliance, combining expertise across the ADC value chain to reduce development timelines and complexity for biopharmaceutical companies. Viralgen collaborated with Trogenix to rapidly scale product supply for TGX-007, an AAV gene therapy for glioblastoma (a type of cancer of the brain and spinal cord).  Silexion announced a collaboration with Catalent for small interfacing RNA (siRNA) development and manufacturing. Catalent’s Limoges (France) facility will conduct formulation development and clinical manufacturing for Silexion’s SIL204 candidate, supporting both systemic and intra-tumoral delivery formulations.Skyepharma’s collaboration with Eneapharm through the Skyehub platform aims to support the treatment of patients suffering from exocrine pancreatic insufficiency, including those affected by cystic fibrosis or pancreatic cancer. Orion Corporation reached an agreement with Shilpa Biocare for the distribution of recombinant human albumin in Europe.Meanwhile, Aenova announced the launch of its Aenovation program, an initiative designed to fast-track early development of pharmaceutical formulations. The program addresses the critical challenges of bioavailability and time-to-market faced by poorly soluble drug candidates. View CDMO Activity Tracker for Q2 2025 (Free Excel Available) Our view The quarter saw CDMO developments mimic the broader trends in the pharmaceutical industry, such as onshoring of critical manufacturing capabilities in the US, consolidation of specialized expertise through strategic partnerships, and the relentless focus on emerging therapeutic modalities that promise to transform patient care. With CDMOs continuing to invest in next-generation manufacturing capabilities, we expect the sector to play a crucial role in drug innovation. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 468

    https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint

    #PharmaFlow by PHARMACOMPASS
    10 Jul 2025
    Share Share

    NEWS #PharmaBuzz

    [Sponsored by another company]read-more
    read-more
    Leo Ponies up €90 Million for Boehringer Ingelheim's Spevigo
    Leo Ponies up €90 Million for Boehringer Ingelheim's Spevigo

    15 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250714349390/en/Boehringer-Ingelheim-and-LEO-Pharma-Enter-Partnership-to-Commercialize-and-Further-Develop-SPEVIGO-spesolimab

    BUSINESSWIRE
    15 Jul 2025
    Share Share
    Delaware Court Backs Zantac Drugmakers in Cancer Lawsuits
    Delaware Court Backs Zantac Drugmakers in Cancer Lawsuits

    12 Jul 2025

    // REUTERS

    https://www.reuters.com/legal/litigation/delaware-supreme-court-sides-with-zantac-drugmakers-over-evidence-2025-07-10/

    REUTERS
    12 Jul 2025
    Share Share
    Boehringer Ingelheim starts Phase II study of BI 1815368
    Boehringer Ingelheim starts Phase II study of BI 1815368

    08 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/07/3110904/0/en/Boehringer-Ingelheim-initiates-Phase-II-study-of-BI-1815368-a-potential-first-in-class-oral-treatment-for-diabetic-macular-edema.html

    GLOBENEWSWIRE
    08 Jul 2025
    Share Share
    Oxford BioTherapeutics Advances Third Oncology Drug
    Oxford BioTherapeutics Advances Third Oncology Drug

    03 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/03/3109680/0/en/Oxford-BioTherapeutics-Announces-Third-Oncology-Drug-Candidate-from-Boehringer-Ingelheim-Collaboration-Selected-to-Advance-into-IND-Enabling-Studies.html

    GLOBENEWSWIRE
    03 Jul 2025
    Share Share
    Boehringer Launches Single-Dose Poultry Vaccine in India
    Boehringer Launches Single-Dose Poultry Vaccine in India

    18 Jun 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/boehringer-ingelheim-launches-single-dose-poultry-vaccine-in-india-covering-three-major-diseases/

    EXPRESSPHARMA
    18 Jun 2025
    Share Share
    Foundation & Boehringer Launch Lung Cancer Research Project
    Foundation & Boehringer Launch Lung Cancer Research Project

    17 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lung-cancer-research-foundation-announces-new-research-collaboration-with-boehringer-ingelheim-302483169.html

    PR NEWSWIRE
    17 Jun 2025
    Share Share
    Contact Boehringer Ingelheim Gmbh and get a quotation

    Boehringer Ingelheim Gmbh is a supplier offers 107 products (APIs, Excipients or Intermediates).

    Find a price of Epinastine Hydrochloride bulk with DMF, CEP, JDMF offered by Boehringer Ingelheim Gmbh

    Find a price of Ipratropium Bromide bulk with DMF, CEP, JDMF offered by Boehringer Ingelheim Gmbh

    Find a price of Repaglinide bulk with DMF, CEP, JDMF offered by Boehringer Ingelheim Gmbh

    Find a price of Digoxin bulk with JDMF offered by Boehringer Ingelheim Gmbh

    Find a price of Pramipexole Dihydrochloride bulk with DMF, CEP offered by Boehringer Ingelheim Gmbh

    Find a price of Salbutamol Sulphate bulk with DMF, CEP offered by Boehringer Ingelheim Gmbh

    Find a price of Scopolamine Hydrobromide bulk with JDMF offered by Boehringer Ingelheim Gmbh

    Find a price of Dipyridamole bulk with DMF offered by Boehringer Ingelheim Gmbh

    Find a price of Hyoscine Butyl Bromide bulk with CEP offered by Boehringer Ingelheim Gmbh

    Find a price of Tiotropium Bromide bulk with CEP offered by Boehringer Ingelheim Gmbh

    Find a price of Atropine bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Atropine Sulfate bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Brotizolam bulk with CEP offered by Boehringer Ingelheim Gmbh

    Find a price of Clenbuterol Hydrochloride bulk with CEP offered by Boehringer Ingelheim Gmbh

    Find a price of Clonidine bulk with CEP offered by Boehringer Ingelheim Gmbh

    Find a price of Dihydroergotamine Mesylate bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Epinephrine bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Epinephrine Bitartrate bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Ergotamine Tartrate bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Etilefrine bulk with CEP offered by Boehringer Ingelheim Gmbh

    Find a price of Fenoterol Hydrobromide bulk with CEP offered by Boehringer Ingelheim Gmbh

    Find a price of Homatropine Hydrobromide bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Homatropine Methylbromide bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Hyoscyamine Sulfate bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Methocarbamol bulk with DMF offered by Boehringer Ingelheim Gmbh

    Find a price of Methylphenidate Hydrochloride bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Moxonidine bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Phenylephrine Hydrochloride bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Pramipexole Dihydrochloride bulk with CEP offered by Boehringer Ingelheim Gmbh

    Find a price of Scopolamine bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Tramazoline Hydrochloride Monohydrate bulk with CEP offered by Boehringer Ingelheim Gmbh

    Find a price of Trospium Chloride bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Zolpidem Tartrate bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Medium / Medium Additives-P-Media bulk with JDMF offered by Boehringer Ingelheim Gmbh

    Find a price of Beperuminogen per plasmid bulk with JDMF offered by Boehringer Ingelheim Gmbh

    Find a price of Medium / Medium Additives / G-Medium bulk with JDMF offered by Boehringer Ingelheim Gmbh

    Find a price of Medium / Medium Additives-I-Medium bulk with JDMF offered by Boehringer Ingelheim Gmbh

    Find a price of Medium / Medium Additives ・ F-Media bulk with JDMF offered by Boehringer Ingelheim Gmbh

    Find a price of Amphetamine Sulfate bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Beta-2 bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Brompheniramine Maleate bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Caffeine bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Calcium Polycarbophil bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Camptothecine bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Crotamiton bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Dexrazoxane bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Digoxin bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Dihydroergotoxine Mesylate bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Doxapram Hydrochloride bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Esmolol Hydrochloride bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Fentanyl bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Fentanyl Citrate bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Glycopyrronium Bromide bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Guaifenesin bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Isoproterenol Hydrochloride bulk offered by Boehringer Ingelheim Gmbh

    Find a price of L-Lactide bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Lanthanum Carbonate bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Lobeline Sulfate bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Meloxicam bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Metaproterenol Hemisulfate bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Metaxalone bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Methadol Hydrochloride bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Methadone Hydrochloride bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Methscopolamine Bromide bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Methscopolamine Nitrate bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Metoclopramide bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Milrinone bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Physostigmine Salicylate bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Pilocarpine Hydrochloride bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Ranitidine Hydrochloride bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Scopolamine Hydrobromide bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Theophylline bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Tiotropium Bromide bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Yohimbine Hydrochloride bulk offered by Boehringer Ingelheim Gmbh

    Find a price of rTNF-alpha Drug Substance bulk offered by Boehringer Ingelheim Gmbh

    Find a price of IFN-OMEGA bulk offered by Boehringer Ingelheim Gmbh

    Find a price of POLY-(D,L-LACTIDE-CO-GLYCOLIDE) 50:50 bulk offered by Boehringer Ingelheim Gmbh

    Find a price of PHYSOSTIGMINE SALICYLATE (SYNTHETIC bulk offered by Boehringer Ingelheim Gmbh

    Find a price of INTERLEUKIN-12 BULK SUBSTANCE bulk offered by Boehringer Ingelheim Gmbh

    Find a price of ESERETHOL bulk offered by Boehringer Ingelheim Gmbh

    Find a price of PRODUCTION AND DISTRIBUTION FACILITY IN DANBURY, CONNECTICUT bulk offered by Boehringer Ingelheim Gmbh

    Find a price of NR-LU-10 MURINE MONOCLONAL ANTIBODY FAB FRAGMENT (NOFETUMOMAB) AND PHENTHIOATE LIGAND BULK MATERIAL FOR ONCOTRAC KIT (NEORX) bulk offered by Boehringer Ingelheim Gmbh

    Find a price of COPOLYMERS OF TRIMETHYLENE CARBONATE WITHL- OR D,L-LACTIDE bulk offered by Boehringer Ingelheim Gmbh

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN RIDGEFIELD, CONNECTICUT. bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Acepromazine bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Aldesleukin bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Alteplase bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Ampicillin bulk offered by Boehringer Ingelheim Gmbh

    Find a price of apatinib mesylate bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Bromhexine Hydrochloride bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Clenbuterol Hydrochloride bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Dabigatran Etexilate Mesylate bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Empagliflozin bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Firocoxib bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Interferon Beta 1B bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Linagliptin bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Nintedanib Esylate bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Olodaterol Hydrochloride bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Penethamate Hydriodide bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Pimobendan bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Tafasitamab bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Tenecteplase bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Tipranavir bulk offered by Boehringer Ingelheim Gmbh

    Find a price of Tylosin bulk offered by Boehringer Ingelheim Gmbh

    Find a price of bulk offered by Boehringer Ingelheim Gmbh

    Find a price of MANUFACTURING OPERATIONS bulk offered by Boehringer Ingelheim Gmbh

    Find a price of ML-3,314,163 bulk offered by Boehringer Ingelheim Gmbh